# Trade Mark Journal No.2026/029 17 July 2026

## WO0000001925337 (5)

Office of origin: United States of America

Date of International Registration:20 April 2026
Date of designation in the UK: 20 April 2026

International priority date claimed: 20 November 2025 (United States of America) (99507742)

Class 5
  Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease.

PRIOVANT THERAPEUTICS, INC.

Representative: Lisa L. Mueller Casimir Jones, S.C., 2275 Deming Way,, Ste. 310, Middleton WI 53562, UNITED STATES OF AMERICA